CVR: 32945945
Secondary names: LEKAFORM A/S, CE-PRODUKTER A/S, CE-PELLETS CONSULTING A/S
DKK 10,369,416
Gross profit
Net result: DKK 5,517,066
LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS
1 more
CVR · view ownership and management
Owner registered: LKJ HOLDING 2010 ApS
CVR · 20/06/2024
View the full event history
LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.
Source: annual report 2025, Danish Business Authority
LEKAPHARM A/S demonstrates a positive financial trajectory, with gross profit increasing significantly from 2,968,088 DKK in 2022 to 10,369,416 DKK in 2025, while profit rose from 4,591 DKK to 5,517,066 DKK over the same period. The company's equity has also shown growth, reaching 7,972,163 DKK in 2025, indicating a solid financial foundation. However, the absence of revenue data raises concerns about transparency and overall sales performance. With a focus on the wholesale distribution of food products, LEKAPHARM appears to be strengthening its position within the industry, although the unknown employee count may suggest limited operational scale.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive virksomhed med produktion, ompakning og salg af kosttilskud samt dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 10.4 mio. | 5.5 mio. | 17.8 mio. | 8 mio. | 4 | |
| 202401/01/2024 – 31/12/2024 | 6.2 mio. | 2.1 mio. | 18 mio. | 5.5 mio. | 4 | |
| 202301/01/2023 – 31/12/2023 | 3.5 mio. | 465 t. | 13.9 mio. | 6.4 mio. | 4 | |
| 202201/01/2022 – 31/12/2022 | 3 mio. | 5 t. | 11.4 mio. | 5.9 mio. | 5 | |
| 202101/01/2021 – 31/12/2021 | 4.2 mio. | 459 t. | 15.2 mio. | 6.4 mio. | 5 | |
| 202001/01/2020 – 31/12/2020 | 3.6 mio. | 404 t. | 15.1 mio. | 9.9 mio. | 3 | |
| 201901/01/2019 – 31/12/2019 | 3.3 mio. | 633 t. | 17.9 mio. | 10 mio. | 3 | |
| 201801/01/2018 – 31/12/2018 | 3.9 mio. | 1.1 mio. | 17.7 mio. | 10.4 mio. | 3 | |
| 201701/01/2017 – 31/12/2017 | 5.5 mio. | 2.5 mio. | 15.4 mio. | 10.3 mio. | 4 | |
| 201601/01/2016 – 31/12/2016 | 6.7 mio. | 3.2 mio. | 17.5 mio. | 10.3 mio. | 5 | |
| 201501/01/2015 – 31/12/2015 | 5.3 mio. | 1.9 mio. | 12.8 mio. | 8.7 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 5.2 mio. | 1.6 mio. | 16.3 mio. | 12.9 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 4.5 mio. | 1 mio. | 14.2 mio. | 11.8 mio. | - | |
| 201201/01/2012 – 31/12/2012 | - | - | - | - | - |
Compared to 333 companies in Engroshandel med andre fødevarer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorLEKAPHARM A/S was founded on 4 June 2010.
LEKAPHARM A/S is registered under the industry Engroshandel med andre fødevarer (industry code 463800).
LEKAPHARM A/S had 3 employees in 2018 according to the Danish CVR register.
LEKAPHARM A/S is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS.
In 2025, LEKAPHARM A/S reported a gross profit of DKK 10,369,416.
The management of LEKAPHARM A/S consists of Lasse Kjeldsen.
Claim this page to add your logo and social links. Free to get started.
LEKAPHARM A/S has published its annual report for 2025. Gross profit came to DKK 10,369,416, and the net result was DKK 5,517,066.
LEKAPHARM A/S has published its annual report for 2024. Gross profit came to DKK 6,178,723, and the net result was DKK 2,051,529.
As of June 20, 2024, LKJ HOLDING 2010 ApS is registered as an owner of LEKAPHARM A/S with an ownership share of 50%.
As of June 20, 2024, CE-PHARMAMACHINERY ApS is registered as an owner of LEKAPHARM A/S with an ownership share of 33%.
As of June 20, 2024, Familien Kjeldsen Holding ApS is registered as an owner of LEKAPHARM A/S with an ownership share of 15%.
LEKAPHARM A/S has published its annual report for 2023. Gross profit came to DKK 3,450,083, and the net result was DKK 464,824.
LEKAPHARM A/S has published its annual report for 2022. Gross profit came to DKK 2,968,088, and the net result was DKK 4,591.
LEKAPHARM A/S has published its annual report for 2021. Gross profit came to DKK 4,218,210, and the net result was DKK 458,999.
As of May 20, 2022, Emil Bødker Kjeldsen has joined the board of directors of LEKAPHARM A/S.
As of May 20, 2022, Jacob Penney Kjeldsen has left the board of directors of LEKAPHARM A/S.
As of May 20, 2022, Claus Skærsholm Kjeldsen has left the board of directors of LEKAPHARM A/S.
LEKAPHARM A/S has published its annual report for 2020. Gross profit came to DKK 3,563,361, and the net result was DKK 403,544.
LEKAPHARM A/S has published its annual report for 2019. Gross profit came to DKK 3,272,989, and the net result was DKK 633,133.
LEKAPHARM A/S has published its annual report for 2018. Gross profit came to DKK 3,915,671, and the net result was DKK 1,138,029.
LEKAPHARM A/S has published its annual report for 2017. Gross profit came to DKK 5,479,773, and the net result was DKK 2,496,719.
LEKAPHARM A/S has published its annual report for 2016. Gross profit came to DKK 6,705,436, and the net result was DKK 3,205,599.
LEKAPHARM A/S has published its annual report for 2015. Gross profit came to DKK 5,260,469, and the net result was DKK 1,873,272.
LEKAPHARM A/S has published its annual report for 2014. Gross profit came to DKK 5,217,509, and the net result was DKK 1,590,630.
LEKAPHARM A/S has published its annual report for 2013. Gross profit came to DKK 4,482,090, and the net result was DKK 1,047,864.
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of LEKAPHARM A/S.
As of October 1, 2013, ND REVISION ODENSE REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of LEKAPHARM A/S.
LEKAPHARM A/S has published its annual report for 2012.
As of October 22, 2010, ND REVISION ODENSE REGISTRERET REVISIONSAKTIESELSKAB has been appointed auditor of LEKAPHARM A/S.
As of October 22, 2010, JUT NR. 2180 A/S has stepped down as auditor of LEKAPHARM A/S.
As of June 4, 2010, JUT NR. 2180 A/S has been appointed auditor of LEKAPHARM A/S.
As of June 4, 2010, Lasse Kjeldsen has joined the board of directors of LEKAPHARM A/S.
As of June 4, 2010, Jacob Penney Kjeldsen has joined the board of directors of LEKAPHARM A/S.
As of June 4, 2010, Susanne Frederiksen has joined the board of directors of LEKAPHARM A/S.
As of June 4, 2010, Claus Skærsholm Kjeldsen has joined the board of directors of LEKAPHARM A/S.
As of June 4, 2010, Lasse Kjeldsen is registered as director of LEKAPHARM A/S.
LEKAPHARM A/S was founded on June 4, 2010.
Companies in the same industry and area
